Opportunities for control of coronary heart disease in Australia

Australian and New Zealand Journal of Public Health

Volumn 25, Issue 1, 2001, Pages 24-30

  McElduff, Patrick ^a   Dobson, Annette J ^b   Jamrozik, Konrad ^c   Hobbs, Michael S T ^c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STREPTOKINASE;

ADULT; AGED; ARTICLE; AUSTRALIA; BEHAVIOR; CHOLESTEROL DIET; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; COST OF ILLNESS; CRISIS INTERVENTION; DISABILITY; DISEASE CONTROL; EXERCISE; FEMALE; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPULATION RISK; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; REDUCTION; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SMOKING; SMOKING CESSATION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AUSTRALIA; CORONARY DISEASE; EXERCISE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; PRIMARY PREVENTION; RISK FACTORS; RISK MANAGEMENT; SMOKING;

EID: 0035082725     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2001.tb00545.x     Document Type: Article

References (33)

1. Trends in cardiovascular disease mortality in industrialized countries since 1950
2. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
3. Changes in estimated coronary risk in the 1980s: Data from 38 populations in the WHO MONICA Project
4. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316, 099 white men
5. Blood pressure, stroke, and coronary heart disease. Part 2. Short term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
6. Effect of statins on risk of coronary heart disease. A meta-analysis of randomized controlled trials
7. Rapid reduction in coronary risk for those who quit cigarette smoking
8. Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993
9. The primary prevention of myocardial infarction
10. An overview of randomised trials of rehabilitation with exercise after myocardial infarction
11. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
12. Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence
13. Randomised trial of intravenous atenolol among 16, 027 cases of suspected acute myocardial infarction: ISIS-1
14. β Blockade after myocardial infarction: Systematic review and meta regression analysis
15. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection
16. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
17. Effect of coronary artery bypass graft surgery on survival: Overview of 10 year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
18. Meta-analysis of randomised trials comparing angioplasty with bypass surgery
19. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up
20. Joint British recommendations on prevention of coronary heart disease in clinical practice: Summary
21. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
22. Detecting differences in quality of care: The sensitivity of measures of process and outcome in treating acute myocardial infarction
23. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction
24. Population versus clinical view of case fatality from acute coronary heart disease. Results from the WHO MONICA Project 1985-1990
25. Hypertension in the elderly. Implications and generalizability of randomized trials
26. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial
27. The occurrence of lung cancer in man
28. Estimation of the possible effect of interventive measures in the area of ischemic heart diseases by the attributable risk percentage